Company / Operating Margin
Xenetic Biosciences, Inc. Operating Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-168.2%
FY2025
5-year range
-3189.8% / -168.2%
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has increased for 5 consecutive years, from -75511.7% in FY2020 to -168.2% in FY2025.
Based on SEC 10-K filings.
-168.2% in FY2025 with a 5-year CAGR of +75343.6%.
Improved from -393.6% to -168.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +327.0pp
- 5-Year Change
- +75343.6pp
- 10-Year Change
- -
Key checks
Key Insights
- Xenetic Biosciences, Inc.'s operating margin has grown for 5 consecutive years.
- In FY2025, operating margin increased 5.4% year-over-year.
- Peak operating margin was recorded in FY2018.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -168.2% | +5.4% |
| FY2024 | -177.8% | +54.8% |
| FY2023 | -393.6% | +20.5% |
| FY2022 | -495.1% | +84.5% |
| FY2021 | -3189.8% | +95.8% |
| FY2020 | -75511.7% | - |
| FY2019 | - | - |
| FY2018 | -47.0% | +97.0% |
| FY2017 | -1581.0% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026